Navigation Links
Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
Date:9/19/2008

OpenClinica 2.5 represents a significant milestone for the growing open source clincial trials software. This release contains a host of improvements particularly oriented towards the needs of regulated industry sponsored clinical trials.

Cambridge, MA (PRWEB) September 19, 2008 -- Akaza Research announces the availability of OpenClinica 2.5, the popular open source http://www.openclinica.org/section.php?sid=1 [clinical trials software]. This release marks a major milestone for users of OpenClinica by adding a host of features, many of which are designed to better support regulated industry sponsored clinical trials.

OpenClinica 2.5 is freely available for download at http://www.openclinica.org.

Among the numerous improvements that comprise this release are:

-   New study monitoring and query management tools and reports
-   Import of data from external sources
-   Enhanced eCRF features, including scoring, multivariate edit checks, and rules
-   User roles for monitors and data managers
-   Electronic signature capabilities
-   Improved auditing and logging capabilities
-   Simpler CRF upload

In addition, this release provides a number of architectural enhancements:

-   Faster performance and improved scalability
-   Out-of-the box support for the Oracle database
-   Translation into 3 new languages: French, Italian, and Portuguese

"Many thanks to our partners in the OpenClinica community who have contributed to this substantial release," said Paul Galvin, who manages OpenClinica development for Akaza Research. Galvin states that a growing proportion of OpenClinica's improvements are coming from community contributions. "Our development team is spending more and more time collaborating with 3rd-party developers who provide code improvements. Just as valuable are the contributions from a core of dedicated end-users who provide ideas, feedback, and testing from the start of development through the final beta and release candidates."

Akaza Research places code contributions it receives through rigorous vetting and validation procedures to ensure the open source software it distributes meet the quality and regulatory demands of the clinical trials industry. According to Akaza this version of OpenClinica has been more heavily tested than any before. Users of OpenClinica Enterprise, the commercial distribution of the OpenClinica source code, will have access to more than 260 test cases and the reports resulting from thousands of hours of testing.

The release of OpenClinica 2.5 also marks a proud day for Cal Collins, Akaza's CEO. "There is tremendous excitement and anticipation among OpenClinica users for this release, and they will not be disappointed." When asked what he feels is most significant about this release, Collins replied: "Version 2.5 is an excellent demonstration of how a motivated open source community can produce world-class enterprise software."

Akaza Research will be conducting a webinar to present OpenClinica on October 7th, 2008. Registration for this event is available here:

- https://www2.gotomeeting.com/register/974214354 [Webinar @ 19:00 - 20:30 (GMT -5:00)]
- https://www2.gotomeeting.com/register/653567155 [Webinar @ 9:30 - 11:00 (GMT - 5:00)]


About OpenClinica®
OpenClinica is open source software for electronic data capture (EDC) and clinical data management. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 regulations and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for download at http://www.OpenClinica.org.

About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/clinicaltrialssoftware/electronicdatacapture/prweb1356434.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
2. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
3. Amicus Therapeutics Opens Research Facility in San Diego
4. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
5. $1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope
6. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
7. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
8. Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
9. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
10. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
11. Dartmouth researchers advance cellulosic ethanol production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials 
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):